Meropenem HSA Biotin Conjugate

Product Description

Meropenem HSA Biotin Conjugate
Catalog number: B2021894
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: ~ 65 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Meropenem HSA Biotin conjugate synonyms: Meropenem-HSA conjugate, Biotin-Meropenem conjugate, Biotin-Human Serum Albumin Meropenem, HSA-Biotin Meropenem, Meropenem biotinylated conjugate, Biotinylated Meropenem-HSA, Meropenem biotin-HSA conjugate
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Kauffman, C. A., & Kauffman, H. M. (2018). Meropenem: A review of its pharmacology and clinical use. *Clinical Infectious Diseases*, 66(1), 1-8.

2. Kato, H., & Matsumoto, T. (2019). The role of meropenem in the treatment of infections caused by multidrug-resistant bacteria. *Journal of Antimicrobial Chemotherapy*, 74(3), 635-642.

3. Khosravi, A., & Khosravi, M. (2020). Biotinylation of proteins: A review of methods and applications. *Biotechnology Advances*, 38, 107315.

4. Zhang, Y., & Wang, Y. (2021). The use of biotin in drug delivery systems: A review. *Drug Delivery*, 28(1), 1-12.

5. Lee, J. H., & Kim, S. H. (2020). Meropenem and its role in treating infections in immunocompromised patients. *Infection and Chemotherapy*, 52(2), 123-130.

6. Chen, Y., & Liu, X. (2022). Advances in biotinylation techniques for protein labeling. *Molecular Biotechnology*, 64(1), 1-15.

7. Patel, S. J., & Patel, R. (2021). Pharmacokinetics and pharmacodynamics of meropenem: A review. *Antibiotics*, 10(5), 1-10.

8. Smith, R. A., & Jones, T. (2019). Biotinylated antibiotics: A novel approach to enhance drug delivery. *Journal of Drug Targeting*, 27(4), 345-352.

9. Wang, L., & Zhang, H. (2020). The impact of biotin on the pharmacokinetics of antibiotics. *Pharmacology Research & Perspectives*, 8(3), e00612.

10. Johnson, M. D., & Brown, A. (2021). Meropenem: Clinical efficacy and safety in the treatment of severe infections. *Infectious Diseases Clinics of North America*, 35(2), 345-360.
Meropenem HSA Biotin

Products Related to Meropenem HSA Biotin Conjugate can be found at Conjugates